TH152843A - - Google Patents

Info

Publication number
TH152843A
TH152843A TH1401003357A TH1401003357A TH152843A TH 152843 A TH152843 A TH 152843A TH 1401003357 A TH1401003357 A TH 1401003357A TH 1401003357 A TH1401003357 A TH 1401003357A TH 152843 A TH152843 A TH 152843A
Authority
TH
Thailand
Prior art keywords
nanoparticles
involves
eminently
regards
mammals
Prior art date
Application number
TH1401003357A
Other languages
English (en)
Thai (th)
Original Assignee
นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Filing date
Publication date
Application filed by นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ filed Critical นายจักรพรรดิ์ มงคลสิทธิ์ นางสาวปรับโยชน์ ศรีกิจจาภรณ์ นายรุทร นพคุณ
Publication of TH152843A publication Critical patent/TH152843A/th

Links

TH1401003357A 2012-12-17 TH152843A (cg-RX-API-DMAC7.html)

Publications (1)

Publication Number Publication Date
TH152843A true TH152843A (cg-RX-API-DMAC7.html) 2016-06-07

Family

ID=

Similar Documents

Publication Publication Date Title
Zamora-Ros et al. Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits
PH12018500843A1 (en) Compositions and methods for treating and/or preventing cardiovascular disease
HK1203353A1 (en) Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
WO2010048623A8 (en) Medical and imaging nanoclusters
BR112014001741A2 (pt) metal em pó compacto extrusado
WO2014158811A8 (en) Newcastle disease viruses and uses thereof
BR112015015319A2 (pt) composições de nanopartícula de albumina e paclitaxel
EP4403570A3 (en) Anti-il-33 antibodies and uses thereof
EP4385572A3 (en) Bispecific antibody capable of being combined with immune cells to enhance tumor killing capability, and preparation method therefor and application thereof
WO2012017324A3 (en) Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases
BR112013004829A2 (pt) composição de agente de dispersão de produto químico agrícola, composição química agrícola, método para produzir um produto agrícola, método para aumentar eficácia em um produto químico agrícola, e uso da composição de agente de dispersão de produto químico agrícola.
FR3009645B1 (fr) Compositions de nanoparticules d'oxydes metalliques transparents, procedes de fabrication de celles-ci et articles comprenant celles-ci
EP2851446A4 (en) RESOURCE-SAVING TITANIUM ALLOYING ELEMENT WITH EXCELLENT STRENGTH AND TENSILE AND METHOD FOR PRODUCING THEREOF
BR112014015331A8 (pt) materiais hemostáticos e dispositivos com particulados galvânicos
JP2012528941A5 (cg-RX-API-DMAC7.html)
WO2017079403A3 (en) Polymeric nanoparticles
Fox et al. The use of doppelgangers to promote health and behavior change
EP3150632A3 (en) Anti-ricin antibodies and uses thereof
TH152843A (cg-RX-API-DMAC7.html)
PT2895192T (pt) Uma composição farmacêutica compreendendo uma nanopartícula sólida e pelo menos um antígeno para o tratamento contra um agente patogénico intracelular
FR3002414B1 (fr) Composition rodenticide sous forme de cereales et/ou de graines agglomerees.
BR112012006267A2 (pt) processo para produzir partículas de substrato orgânico ligadas a nanopartículas ferromagnéticas comutáveis, partículas de substrato para diagnóstico, uso de nanopartículas ferromagnéticas comutáveis, e, medicamento para o tratamento de hipertermia no corpo humano ou animal
IN2014DN11097A (cg-RX-API-DMAC7.html)
Bannai et al. Maximal m-distance sets containing the representation of the Johnson graph J (n, m)
박보미 Living Environment and Policy Issues for the Aged